BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 33907514)

  • 1. The role of CD4
    Wang Y; Zheng J; Islam MS; Yang Y; Hu Y; Chen X
    Int J Biol Sci; 2021; 17(6):1507-1520. PubMed ID: 33907514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dynamic Role of FOXP3
    Xu Z; Jiang X; Dai X; Li B
    Front Immunol; 2022; 13():916411. PubMed ID: 35874688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
    Uraki R; Imai M; Ito M; Shime H; Odanaka M; Okuda M; Kawaoka Y; Yamazaki S
    PLoS Pathog; 2021 Dec; 17(12):e1010085. PubMed ID: 34882757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
    Pourgholaminejad A; Pahlavanneshan S; Basiri M
    Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T Cells in Immunopathogenesis and Severity of COVID-19: A Systematic Review.
    Alahyari S; Rajaeinejad M; Jalaeikhoo H; Amani D
    Arch Iran Med; 2022 Feb; 25(2):127-132. PubMed ID: 35429952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.
    Miyara M; Sakaguchi S
    Immunol Cell Biol; 2011 Mar; 89(3):346-51. PubMed ID: 21301480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic effects of interleukin-35 on the differentiation of naïve T cells into Helios
    Wang C; Xie K; Li K; Lin S; Xu F
    Mol Immunol; 2021 Apr; 132():236-249. PubMed ID: 33494935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.
    Pierini A; Strober W; Moffett C; Baker J; Nishikii H; Alvarez M; Pan Y; Schneidawind D; Meyer E; Negrin RS
    Blood; 2016 Aug; 128(6):866-71. PubMed ID: 27365424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19.
    Saghafi N; Rezaee SA; Momtazi-Borojeni AA; Tavasolian F; Sathyapalan T; Abdollahi E; Sahebkar A
    Life Sci; 2022 Apr; 294():120392. PubMed ID: 35149115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fox3
    Girija ASS
    J Med Virol; 2021 Oct; 93(10):5673-5675. PubMed ID: 32881026
    [No Abstract]   [Full Text] [Related]  

  • 11. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.
    Franceschini D; Paroli M; Francavilla V; Videtta M; Morrone S; Labbadia G; Cerino A; Mondelli MU; Barnaba V
    J Clin Invest; 2009 Mar; 119(3):551-64. PubMed ID: 19229109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CD4
    Khantakova J; Tereshchenko V; Kurilin V; Silkov A; Maksyutov A; Lopatnikova J; Shevchenko J; Knauer N; Kulikova E; Sennikov S
    J Interferon Cytokine Res; 2019 Sep; 39(9):531-538. PubMed ID: 31070504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
    Tahmasebi S; Saeed BQ; Temirgalieva E; Yumashev AV; El-Esawi MA; Navashenaq JG; Valizadeh H; Sadeghi A; Aslani S; Yousefi M; Jadidi-Niaragh F; Adigozalou J; Ahmadi M; Roshangar L
    Life Sci; 2021 Jul; 276():119437. PubMed ID: 33789145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Front Immunol; 2020; 11():589380. PubMed ID: 33178221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.
    Yuan XL; Chen L; Zhang TT; Ma YH; Zhou YL; Zhao Y; Wang WW; Dong P; Yu L; Zhang YY; Shen LS
    World J Gastroenterol; 2011 Apr; 17(15):2019-27. PubMed ID: 21528082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Niedźwiecki M; Budziło O; Zieliński M; Adamkiewicz-Drożyńska E; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
    J Immunol Res; 2018; 2018():1292404. PubMed ID: 30003111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Functions of Regulatory T Cells in Tissue Homeostasis.
    Sharma A; Rudra D
    Front Immunol; 2018; 9():883. PubMed ID: 29887862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    Nam H; Koh JY; Jung JH; Jeong H; Jeong HW; Cheon S; Park SH; Kim YS; Shin EC
    J Immunol; 2023 Jun; 210(11):1687-1699. PubMed ID: 37042681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovariectomized OVA-sensitized mice display increased frequency of CD4(+)Foxp3(+) T regulatory cells in the periphery.
    Ligeiro de Oliveira AP; Peron JP; Santos Franco AL; Golega BA; Vieira RP; Ibanez OC; Ribeiro OG; Cabrera WH; De Franco M; Oliveira-Filho RM; Rizzo LV; Vargaftig BB; de Lima WT
    PLoS One; 2013; 8(6):e65674. PubMed ID: 23799034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
    Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G
    Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.